Free Trial

Gilead Sciences (GILD) News Today

$65.68
-0.49 (-0.74%)
(As of 05/24/2024 04:00 PM ET)
United Services Automobile Association Buys 90,194 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
United Services Automobile Association lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 67.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 222,985 shares of the biopharma
Intech Investment Management LLC Sells 141,024 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Intech Investment Management LLC lessened its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 27.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 373,106 shares
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Advisory Services Network LLC
Advisory Services Network LLC decreased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 13.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 75,434 shares of the biopharmaceutical company's stock after sell
Nomura Asset Management Co. Ltd. Purchases 14,557 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Nomura Asset Management Co. Ltd. boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 1.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 906,670 shares of the biopharmaceutical company's stock after purcha
Greylin Investment Management Inc Sells 32,265 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Greylin Investment Management Inc cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 33.4% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 64,368 shares of the biopharmaceutical company'
Ontario Teachers Pension Plan Board Trims Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Ontario Teachers Pension Plan Board trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 38.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 56,446 shares
3 Biotech Stocks to Buy Now: May 2024
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dai ichi Life Insurance Company Ltd
Dai ichi Life Insurance Company Ltd decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 56.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 329,283 shares of the biopharmaceutical company's stock after selling 431,
21,827 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Simplicity Wealth LLC
Simplicity Wealth LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 21,827 shares of the biopharmaceutical company's stock, valued at approximately $1,599,000. S
ING Groep NV Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ING Groep NV increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 96.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 931,968 shares of the biopharmaceutical company's stock after acquiring an
Meridian Wealth Management LLC Has $3.31 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Meridian Wealth Management LLC boosted its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 77.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,807 shares of the biopharmaceu
ARGA Investment Management LP Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)
ARGA Investment Management LP boosted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 635,058 shares of the
Gilead Sciences Q1 Earnings Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Position Boosted by Mitsubishi UFJ Asset Management Co. Ltd.
Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,316,128 shares o
Principal Financial Group Inc. Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Principal Financial Group Inc. decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 13.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,459,552 shares of the
QRG Capital Management Inc. Has $32.56 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
QRG Capital Management Inc. raised its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 33.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 401,972 shares of the biopharmaceutic
Dimensional Fund Advisors LP Grows Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Dimensional Fund Advisors LP raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,783,195 shares of the biopharmaceutical comp
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Private Advisor Group LLC
Private Advisor Group LLC trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 39.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 54,510 shares of the biopharmac
National Pension Service Acquires 52,214 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
National Pension Service grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,358,832 shares of the biopharmaceutical company's stock after buying an
Charles Schwab Investment Management Inc. Boosts Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Charles Schwab Investment Management Inc. grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 1.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,281,489 shares of the biophar
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Natixis Advisors L.P.
Natixis Advisors L.P. boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 15.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 279,620 shares of the biopharmaceutical company's sto
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lifted by Sheets Smith Wealth Management
Sheets Smith Wealth Management increased its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 85.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 42,701 shares of the biopharmaceutical company's stock after purchasing an additional 19,64
Todd Asset Management LLC Has $974,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Todd Asset Management LLC decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 95.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 12,023 shares of the bio
Amalgamated Bank Sells 19,072 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Amalgamated Bank reduced its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 300,795 shares of the biopharmaceutical company's
Gilead Sciences (NASDAQ:GILD) Sets New 1-Year Low at $64.42
Gilead Sciences (NASDAQ:GILD) Sets New 1-Year Low at $64.42
McAdam LLC Has $1.63 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
McAdam LLC boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 132.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,258 shares of the biopharmaceutical company's st
Get Gilead Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter.

Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.

7 Cheap Dividend Stocks Offering Value and Price Upside

GILD Media Mentions By Week

GILD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GILD
News Sentiment

1.00

0.92

Average
Medical
News Sentiment

GILD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GILD Articles
This Week

17

16

GILD Articles
Average Week

Get Gilead Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GILD) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners